https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 123, Issue 12, March 2026. <br/>SignificanceAntibody-based therapies rely not only on antigen binding but also on effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cellular phagocytosis (CDCP), both of which are strongly shaped by the …
